Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis

被引:15
|
作者
Dratwa, M
Wilkie, M
Ryckelynck, JP
ter Wee, PM
Rutherford, P
Michel, C
Hopwood, A
Curtis, L
Denys, N
Divino, JC
Faict, D
机构
[1] CHU Brugmann, Brussels, Belgium
[2] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
[3] CHU Clemenceau, Caen, France
[4] Free Univ Amsterdam, Acad Ziekenhuis, NL-1007 MC Amsterdam, Netherlands
[5] NE Wales NHS Trust, Wrexham, Clwyd, Wales
[6] Hop Bichat, F-75877 Paris, France
[7] Baxter Healthcare Corp, Brussels, Belgium
关键词
acidosis; alkalosis; bicarbonate; biocompatibility; lactate; peritoneal dialysis; bicarbonate/lactate; calcium; APD; buffer;
D O I
10.1046/j.1523-1755.2003.08812.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Patients on automated peritoneal dialysis (APD) usually receive larger volumes of dialysis solution and more frequent, shorter exchanges than patients on continuous ambulatory peritoneal dialysis (CAPD), and therefore are likely to derive greater benefit from more physiologic solutions. Methods. Peritoneal dialysis solutions containing 25 mmol/L bicarbonate and either 10 or 15 mmol/L lactate were compared with standard lactate solutions (35 or 40 mmol/L) in two prospective, open-label studies of patients on APD. Each study included a 2-week baseline period (lactate solution), a 6-week treatment period (bicarbonate/lactate solution), and a 2-week follow-up period (same lactate solution as baseline). Biochemical analyses and assessments of vital signs and safety parameters were conducted at baseline, every 2 weeks during treatment, and at the end of the follow-up period. A product use questionnaire was administered in one study at the end of treatment. Results. A statistically significant rise in plasma bicarbonate (approximately 2 mmol/L) occurred when patients switched from a lactate solution to the bicarbonate/lactate solution with equimolar buffer concentration (P<0.001 for each solution). Plasma bicarbonate decreased by 1.16 mmol/L after a switch from lactate 40 mmol/L to bicarbonate/lactate 35 mmol/L (P<0.001). When patients switched to bicarbonate/lactate 35, the majority of individual venous plasma bicarbonate values were in the normal range. A switch from a lower calcium (1.25 mmol/L) lactate solution to a higher calcium (1.75 mmol/L) lactate/bicarbonate solution resulted in a statistically significant rise in serum calcium (0.06 mmol/L, P<0.018). The product use questionnaire revealed improvements in symptoms, including reduced pain on infusion. Conclusion. Bicarbonate/lactate solutions may be used safely and effectively in patients on APD. The availability of 2 formulations with different buffer and calcium content provides flexibility for the control of acidosis as well as calcium balance.
引用
收藏
页码:S105 / S113
页数:9
相关论文
共 50 条
  • [41] Effects of peritoneal dialysis solutions on the peritoneal membrane:: Clinical consequences
    Witowski, J
    Jörres, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2005, 25 : S31 - S34
  • [42] Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis
    Hoshino, Taro
    Kaneko, Shohei
    Minato, Saori
    Yanai, Katsunori
    Mutsuyoshi, Yuko
    Ishii, Hiroki
    Kitano, Taisuke
    Shindo, Mitsutoshi
    Miyazawa, Haruhisa
    Aomatsu, Akinori
    Ito, Kiyonori
    Ueda, Yuichiro
    Hirai, Keiji
    Ookawara, Susumu
    Morishita, Yoshiyuki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (06) : 641 - 648
  • [43] Peritoneal dialysis solutions
    Wang, T
    Lindholm, B
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 : S89 - S95
  • [44] Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: Are There Differences in Outcome?
    Dell'Aquila, R.
    Berlingo, G.
    Pellanda, M. V.
    Contestabile, A.
    PERITONEAL DIALYSIS - FROM BASIC CONCEPTS TO CLINICAL EXCELLENCE, 2009, 163 : 292 - 299
  • [45] Risk of Peritonitis in Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis
    Cheng, Franco W. T.
    Chau, Marco
    Li, Xue
    Liang, Jiahao
    Wong, Ian Chi Kei
    Tang, Sydney C. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 596 - 596
  • [46] Peritoneal dialysis solutions
    Gokal, R
    DIALYSIS & TRANSPLANTATION, 1996, 25 (10) : 667 - &
  • [47] Peritoneal dialysis solutions
    Montenegro, J.
    NEFROLOGIA, 2008, 28 : 59 - 65
  • [48] THE IMPACT OF AUTOMATED PERITONEAL DIALYSIS IN CLINICAL OUTCOMES
    Teixeira, Laetitia
    Rodrigues, Anabela
    Joao Carvalho, M.
    Cabrita, Antonio
    Mendonca, Denisa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [49] Bicarbonate/lactate buffered new biocompatible peritoneal dialysis solutions ameliorate sonographic endothelial dysfunction
    Bolanos, Luis
    Gonzalez-Juanatey, Carlos
    Testa, Ana
    Ranero, Rosa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 255 - 255
  • [50] What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis?
    Diaz-Buxo, JA
    PERITONEAL DIALYSIS TODAY, 2003, 140 : 264 - 271